Reno, Nevada (UroToday.com) -- Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve ...
President Trump on Monday announced plans to build a new fleet of Navy battleships, anchoring what he called the Pentagon's "Golden Fleet." The president said he approved plans to begin constructing ...
Atacicept is an investigational recombinant fusion protein that contains the soluble transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) receptor that binds to the ...
The major histocompatibility complex class I (MHC-I) antigen presentation pathway is central to the adaptive immune response. In this process, intracellular proteins are degraded primarily by the ...
When one accesses the getExtensions() method of an abstract class that implements ExtensionAware a java.lang.NoSuchMethodError is thrown. The conditions for this to ...
Govorestat is a central nervous system (CNS) penetrant Aldose Reductase Inhibitor (ARI) being developed for the treatment of multiple rare diseases including Charcot-Marie-Tooth Sorbitol Dehydrogenase ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Email news briefs and event listings to [email protected]. Rock Talks explores Irish music The Murrysville Community Library and municipal recreation department will host another “Rock Talks!” ...
Introduction: Acute myocardial infarction (MI) induces splenic remodeling and rapid mobilization of immune cells from the spleen to the injured myocardium. Activation of this “cardio-splenic” axis ...
Case presentation: A 64-year-old man presented with one day of chest pain. Initial evaluation showed elevated cardiac enzymes (CE) and normal eosinophil count. Electrocardiogram (EKG) was unremarkable ...
AND017 is a first-in-class hemoglobin elevating agent (HbEA) that targets multiple stages of the red blood cell (RBC) life cycle and is being developed to treat anemia associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results